Vyant Bio to Present at the H.C. Wainwright Bioconnect Conference
10 janv. 2022 08h00 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 2022 BioConnect Conference January 10-13, 2022 (VIRTUAL CONFERENCE)
04 janv. 2022 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 04, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...